跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
張 偉斌
教授
,
醫務管理學系
合聘教授
,
國際生技醫療管理博士學位學程
成員
,
臺北醫學大學人工智慧醫療研究中心
https://orcid.org/0000-0003-2107-612X
電子郵件
wpchang
tmu.edu
tw
h-index
1363
引文
22
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2011
2025
每年研究成果
概覽
指紋
網路
專案
(18)
研究成果
(67)
資料集
(2)
類似的個人檔案
(6)
指紋
查看啟用 Wei Pin Chang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cohort Analysis
100%
Hazard Ratio
68%
Kidney Stone
54%
Cholesteatoma
38%
Kawasaki Disease
38%
Isotopes of Calcium
38%
Disease
34%
Retrospective Cohort Study
28%
Atopic Dermatitis
26%
Endometriosis
25%
Chronic Obstructive Pulmonary Disease
25%
Apoplexy
25%
Functional Gastrointestinal Disorder
25%
Disseminated Herpes Zoster
25%
Malignant Neoplasm
23%
Proportional Hazards Model
23%
Survival Rate
19%
Recurrent Disease
19%
Peritoneum Cancer
19%
Krukenberg Tumor
19%
Urothelial Cancer
17%
Intraperitoneal Chemotherapy
16%
Irritable Bowel Syndrome
14%
Genetic Polymorphism
14%
Preschooler
14%
Calcium Sensing Receptor
14%
Cost-Effectiveness Analysis
14%
Cardiovascular Disease
13%
Allergic Rhinitis
13%
Scoliosis
12%
Nephrectomy
12%
Transitional Cell Carcinoma
12%
Gene Overexpression
12%
Clear Cell Renal Cell Carcinoma
12%
Pervasive Developmental Disorder
12%
Chronic Rhinosinusitis
12%
RGS Protein
12%
Hernioplasty
12%
Osteoporosis
12%
Endometrial Cancer
12%
Electronic Health Record
12%
Inguinal Hernia
12%
Gene Expression
12%
Respiratory Medicine
12%
Breast Cancer
12%
Heart Failure
12%
Major Depressive Episode
12%
Obstructive Sleep Apnea
12%
Alkaline Phosphatase
12%
Receptor Gene
12%
Biochemistry, Genetics and Molecular Biology
Single-Nucleotide Polymorphism
86%
Cohort Study
81%
Intravenous Immunoglobulin
52%
Survival Rate
49%
Allele
42%
ORAI1
38%
Single Nucleotide Polymorphism
31%
Genotyping
29%
Genetic Polymorphism
26%
Population
25%
Genome-Wide Association Study
21%
Prevalence
19%
Genetic Determinism
16%
Haplotype
16%
Promoter Region
16%
Caspase 3
16%
TaqMan
13%
Postmenopause
12%
Bone Remodeling
12%
Sleep Quality
12%
Comorbidity
12%
Coronary Artery Dilatation
12%
Electronic Health Record
12%
Proinflammatory Cytokine
12%
Genetic Risk
12%
Gene Expression
12%
Phospholipase D
12%
Osteopontin
12%
Osteoclast
12%
Osteolysis
12%
DC-SIGN
12%
Aspartate Aminotransferase Blood Level
12%
Albumin Level
12%
Lipid Peroxidation
12%
Alanine Aminotransferase Level
12%
Chi-Square Testing
12%
Gene Frequency
11%
Overall Survival
8%
Somnolence
8%
Dendritic Cell
8%
Haplotype Map
7%
Genetics
6%
Gene Polymorphism
6%
Homozygote
6%
ICD-9-CM
6%
Xanthine Oxidase
6%
Multivariate Analysis
6%
Membrane Lipid
6%
Superoxide Dismutase
6%
Calcium Channel
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
69%
Sleep Disordered Breathing
51%
Survival Rate
30%
Disease
27%
Digestive System Function Disorder
25%
Chronic Obstructive Lung Disease
25%
Chemotherapy
25%
Malignant Neoplasm
23%
Peritoneum Cancer
19%
Ovary Carcinoma
19%
Ankylosing Spondylitis
16%
Intraperitoneal Chemotherapy
16%
Atopic Dermatitis
15%
Cardiovascular Disease
13%
Scoliosis
12%
Abdominal Wall Hernia
12%
Chronic Rhinosinusitis
12%
Nephrolithiasis
12%
Dimethylnitrosamine-Induced Liver Fibrosis
12%
Breast Cancer
12%
Mucocutaneous Lymph Node Syndrome
12%
Paclitaxel
12%
Hernia
12%
Asthma
12%
Prevalence
12%
Postoperative Nausea and Vomiting
12%
Disease Activity
12%
Rheumatoid Arthritis
12%
Phospholipase D
12%
Erectile Dysfunction
12%
Urine Retention
12%
Periodontitis
12%
Drug Dependence
12%
N-Nitrosodimethylamine
12%
Prostate Hypertrophy
12%
Cholesteatoma
12%
Parkinson's Disease
12%
Minimal Residual Disease
12%
Gallstone
12%
Urolithiasis
12%
Drug Repositioning
12%
Pembrolizumab
12%
Non Small Cell Lung Cancer
12%
Immunoglobulin E
10%
Combination Therapy
9%
Liver Fibrosis
8%
Aspartate Aminotransferase
8%
Alanine Aminotransferase
8%
Neoplasm
6%
Recurrent Disease
6%
